Società American BriVision (Holding) Corporation OTC Markets
Azioni
ABVC
US0247332069
Biotecnologia
Attività
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
New Drugs and Medical Devices
100,0
%
| 1 | 100,0 % | 0 | 100,0 % | -84,28% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 1 | 100,0 % | 0 | 100,0 % | -84,28% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Chief Executive Officer | - | 23/06/23 | |
Leeds Chow
DFI | Director of Finance/CFO | 35 | 01/03/21 |
Eugene Jiang
CHM | Chairman | 38 | 01/07/15 |
Chief Tech/Sci/R&D Officer | 70 | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Yue Min Chung
BRD | Director/Board Member | 59 | 10/07/22 |
Shu Ling Chiang
BRD | Director/Board Member | 68 | - |
Eugene Jiang
CHM | Chairman | 38 | 01/07/15 |
Tsang Ming Jiang
BRD | Director/Board Member | 63 | 23/11/17 |
Norimi Sakamoto
BRD | Director/Board Member | 53 | 23/11/17 |
Yen-Hsin Chou
BRD | Director/Board Member | 43 | 23/11/17 |
Chief Tech/Sci/R&D Officer | 70 | - | |
Chang-Jen Jiang
BRD | Director/Board Member | 68 | - |
Yoshinobu Odaira
BRD | Director/Board Member | 76 | - |
Che-Wei Hsu
BRD | Director/Board Member | 43 | - |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 10 878 376 | 8 003 326 ( 73,57 %) | 26 553 ( 0,2441 %) | 73,57 % |
Coordinate società
Settore
Variaz. 1 gen. | Capi. | |
---|---|---|
+16,93% | 123 Mrd | |
+17,01% | 111 Mrd | |
-7,23% | 23,63 Mrd | |
+1,98% | 22,58 Mrd | |
-14,29% | 17,26 Mrd | |
-6,79% | 17,6 Mrd | |
-37,63% | 17,61 Mrd | |
+2,17% | 13,55 Mrd | |
+24,42% | 11,34 Mrd |